{"count": 12, "results": [{"_id": "37071429", "pmid": 37071429, "pmcid": "PMC10242521", "title": "Amlodipine limits microglia activation and cognitive dysfunction in aged hypertensive mice", "journal": "J Hypertens", "authors": ["Kerkhofs D", "Helgers R", "Hermes D", "Steinbusch HPJ", "Van Essen H", "Leenders P", "Prickaerts J", "Staals J", "Biessen EA", "Van Oostenbrugge RJ", "Foulquier S"], "date": "2023-07-01T00:00:00Z", "doi": "10.1097/HJH.0000000000003445", "meta_date_publication": "2023 Jul 1", "meta_volume": "41", "meta_issue": "7", "meta_pages": "1159-1167", "score": 50266.66, "text_hl": "@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ limits microglia activation and @<m>DISEASE_Cognition_Disorders</m> @DISEASE_MESH:D003072 @@@cognitive dysfunction@@@ in aged @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ mice", "citations": {"NLM": "Kerkhofs D, Helgers R, Hermes D, Steinbusch HPJ, Van Essen H, Leenders P, Prickaerts J, Staals J, Biessen EA, Van Oostenbrugge RJ, Foulquier S. Amlodipine limits microglia activation and cognitive dysfunction in aged hypertensive mice J Hypertens. 2023 Jul 1;41(7):1159-1167. PMID: 37071429", "BibTeX": "@article{37071429, title={Amlodipine limits microglia activation and cognitive dysfunction in aged hypertensive mice}, author={Kerkhofs D and Helgers R and Hermes D and Steinbusch HPJ and Van Essen H and Leenders P and Prickaerts J and Staals J and Biessen EA and Van Oostenbrugge RJ and Foulquier S}, journal={J Hypertens}, volume={41}, number={7}, pages={1159-1167}}"}}, {"_id": "36166186", "pmid": 36166186, "title": "Relationship Between Calcium Channel Blockers Therapy and Cognitive Function Improvement in Cognitive Decline Patients with Cerebrovascular Disease.", "journal": "High Blood Press Cardiovasc Prev", "authors": ["Jeong HT", "Sung HH", "Lee JH", "Park KY", "Youn YC"], "date": "2022-11-01T00:00:00Z", "doi": "10.1007/s40292-022-00538-1", "meta_date_publication": "2022 Nov", "meta_volume": "29", "meta_issue": "6", "meta_pages": "595-600", "score": 50259.93, "text_hl": "Changes in MMSE were compared in the target BP reached (TBPR) and non-reached (NTBPR) groups and for CN and @<m>DISEASE_Cognition_Disorders</m> @DISEASE_MESH:D003072 @@@CD@@@ groups. Treatment with 5 mg of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@S-amlodipine besylate@@@ for 24 weeks improved MMSE and GDS scores (p < 0.001). ", "citations": {"NLM": "Jeong HT, Sung HH, Lee JH, Park KY, Youn YC. Relationship Between Calcium Channel Blockers Therapy and Cognitive Function Improvement in Cognitive Decline Patients with Cerebrovascular Disease. High Blood Press Cardiovasc Prev. 2022 Nov;29(6):595-600. PMID: 36166186", "BibTeX": "@article{36166186, title={Relationship Between Calcium Channel Blockers Therapy and Cognitive Function Improvement in Cognitive Decline Patients with Cerebrovascular Disease.}, author={Jeong HT and Sung HH and Lee JH and Park KY and Youn YC}, journal={High Blood Press Cardiovasc Prev}, volume={29}, number={6}, pages={595-600}}"}}, {"_id": "36281672", "pmid": 36281672, "title": "Delayed Decline of Cognitive Function by Antihypertensive Agents: A Cohort Study Linked with Genotype Data.", "journal": "J Prev Alzheimers Dis", "authors": ["Sternberg Z", "Podolsky R", "Yu J", "Tian M", "Hojnacki D", "Schaller B"], "date": "2022-01-01T00:00:00Z", "doi": "10.14283/jpad.2022.73", "meta_date_publication": "2022", "meta_volume": "9", "meta_issue": "4", "meta_pages": "679-691", "score": 50246.918, "text_hl": "Delayed @<m>DISEASE_Cognition_Disorders</m> @DISEASE_MESH:D003072 @@@Decline of Cognitive Function@@@ by Antihypertensive Agents: A Cohort Study Linked with Genotype Data.", "citations": {"NLM": "Sternberg Z, Podolsky R, Yu J, Tian M, Hojnacki D, Schaller B. Delayed Decline of Cognitive Function by Antihypertensive Agents: A Cohort Study Linked with Genotype Data. J Prev Alzheimers Dis. 2022;9(4):679-691. PMID: 36281672", "BibTeX": "@article{36281672, title={Delayed Decline of Cognitive Function by Antihypertensive Agents: A Cohort Study Linked with Genotype Data.}, author={Sternberg Z and Podolsky R and Yu J and Tian M and Hojnacki D and Schaller B}, journal={J Prev Alzheimers Dis}, volume={9}, number={4}, pages={679-691}}"}}, {"_id": "33849417", "pmid": 33849417, "title": "Psychological Continuum of Elderly Patients Suffering from Arterial Hypertension with Metabolic Syndrome, Against the Background of Chronotherapy with a Fixed Combination of Amlodipine, Lisinopril and Rosuvastatin.", "journal": "Kardiologiia", "authors": ["Agarkov NM", "Okhotnikov OI", "Korneeva SI", "Moskaleva EO", "Moskalev AA", "Kolomiets VI", "Markelova AM", "Markelova EA"], "date": "2021-03-30T00:00:00Z", "doi": "10.18087/cardio.2021.3.n1509", "meta_date_publication": "2021 Mar 30", "meta_volume": "61", "meta_issue": "3", "meta_pages": "36-41", "score": 50241.5, "text_hl": "Psychological Continuum of Elderly @SPECIES_9606 @@@Patients@@@ Suffering from @DISEASE_Pulmonary_Arterial_Hypertension @DISEASE_MESH:D000081029 @@@Arterial Hypertension@@@ with @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@Metabolic Syndrome@@@, Against the Background of Chronotherapy with a Fixed Combination of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@, @CHEMICAL_Lisinopril @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@Rosuvastatin@@@.", "citations": {"NLM": "Agarkov NM, Okhotnikov OI, Korneeva SI, Moskaleva EO, Moskalev AA, Kolomiets VI, Markelova AM, Markelova EA. Psychological Continuum of Elderly Patients Suffering from Arterial Hypertension with Metabolic Syndrome, Against the Background of Chronotherapy with a Fixed Combination of Amlodipine, Lisinopril and Rosuvastatin. Kardiologiia. 2021 Mar 30;61(3):36-41. PMID: 33849417", "BibTeX": "@article{33849417, title={Psychological Continuum of Elderly Patients Suffering from Arterial Hypertension with Metabolic Syndrome, Against the Background of Chronotherapy with a Fixed Combination of Amlodipine, Lisinopril and Rosuvastatin.}, author={Agarkov NM and Okhotnikov OI and Korneeva SI and Moskaleva EO and Moskalev AA and Kolomiets VI and Markelova AM and Markelova EA}, journal={Kardiologiia}, volume={61}, number={3}, pages={36-41}}"}}, {"_id": "39181551", "pmid": 39181551, "title": "Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adults.", "journal": "BMJ Open", "authors": ["Carcel C", "Clancy L", "Harris K", "Peters R", "Byrne A", "Bassett K", "Freed R", "Hoyos CM", "Rodgers A", "Lindley R", "Chalmers J", "Xu Y", "Woodward M", "Ouyang M", "Naismith SL", "Anderson C"], "date": "2024-08-24T00:00:00Z", "doi": "10.1136/bmjopen-2023-080862", "meta_date_publication": "2024 Aug 24", "meta_volume": "14", "meta_issue": "8", "meta_pages": "e080862", "score": 50241.094, "text_hl": "Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate @<m>DISEASE_Cognition_Disorders</m> @DISEASE_MESH:D003072 @@@cognitive decline@@@ in high-risk adults.", "citations": {"NLM": "Carcel C, Clancy L, Harris K, Peters R, Byrne A, Bassett K, Freed R, Hoyos CM, Rodgers A, Lindley R, Chalmers J, Xu Y, Woodward M, Ouyang M, Naismith SL, Anderson C. Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adults. BMJ Open. 2024 Aug 24;14(8):e080862. PMID: 39181551", "BibTeX": "@article{39181551, title={Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adults.}, author={Carcel C and Clancy L and Harris K and Peters R and Byrne A and Bassett K and Freed R and Hoyos CM and Rodgers A and Lindley R and Chalmers J and Xu Y and Woodward M and Ouyang M and Naismith SL and Anderson C}, journal={BMJ Open}, volume={14}, number={8}, pages={e080862}}"}}, {"_id": "37021189", "pmid": 37021189, "pmcid": "PMC10069218", "title": "The EffecTs of Amlodipine and other Blood PREssure Lowering Agents on Microvascular FuncTion in Small Vessel Diseases (TREAT-SVDs) trial: Study protocol for a randomised crossover trial", "journal": "Eur Stroke J", "authors": ["Kopczak A", "S Stringer M", "van den Brink H", "Kerkhofs D", "W Blair G", "van Dinther M", "Onkenhout L", "A Wartolowska K", "Thrippleton MJ", "Duering M", "Staals J", "Middeke M", "André E", "Norrving B", "Bousser MG", "Mansmann U", "Rothwell PM", "N Doubal F", "van Oostenbrugge R", "Jan Biessels G", "Webb AJ", "Wardlaw JM", "Dichgans M"], "date": "2023-03-01T00:00:00Z", "doi": "10.1177/23969873221143570", "meta_date_publication": "2023 Mar", "meta_volume": "8", "meta_issue": "1", "meta_pages": "387-397", "score": 50240.65, "text_hl": "Sporadic @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Cognition_Disorders</m> @DISEASE_MESH:D003072 @@@vascular cognitive impairment@@@ are eligible for study inclusion if they are visiting a memory clinic with cognitive complaints and are diagnosed with objective @<m>DISEASE_Cognition_Disorders</m> @DISEASE_MESH:D003072 @@@cognitive impairment@@@ as documented by a validated cognitive assessment tool. ", "citations": {"NLM": "Kopczak A, S Stringer M, van den Brink H, Kerkhofs D, W Blair G, van Dinther M, Onkenhout L, A Wartolowska K, Thrippleton MJ, Duering M, Staals J, Middeke M, André E, Norrving B, Bousser MG, Mansmann U, Rothwell PM, N Doubal F, van Oostenbrugge R, Jan Biessels G, Webb AJ, Wardlaw JM, Dichgans M. The EffecTs of Amlodipine and other Blood PREssure Lowering Agents on Microvascular FuncTion in Small Vessel Diseases (TREAT-SVDs) trial: Study protocol for a randomised crossover trial Eur Stroke J. 2023 Mar;8(1):387-397. PMID: 37021189", "BibTeX": "@article{37021189, title={The EffecTs of Amlodipine and other Blood PREssure Lowering Agents on Microvascular FuncTion in Small Vessel Diseases (TREAT-SVDs) trial: Study protocol for a randomised crossover trial}, author={Kopczak A and S Stringer M and van den Brink H and Kerkhofs D and W Blair G and van Dinther M and Onkenhout L and A Wartolowska K and Thrippleton MJ and Duering M and Staals J and Middeke M and André E and Norrving B and Bousser MG and Mansmann U and Rothwell PM and N Doubal F and van Oostenbrugge R and Jan Biessels G and Webb AJ and Wardlaw JM and Dichgans M}, journal={Eur Stroke J}, volume={8}, number={1}, pages={387-397}}"}}, {"_id": "34994269", "pmid": 34994269, "title": "Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress.", "journal": "Int J Stroke", "authors": ["Anderson CS", "Rodgers A", "de Silva HA", "Martins SO", "Klijn CJ", "Senanayake B", "Freed R", "Billot L", "Arima H", "Thang NH", "Zaidi WAW", "Kherkheulidze T", "Wahab K", "Fisher U", "Lee TH", "Chen C", "Pontes-Neto O", "Robinson T", "Wang J", "Naismith S", "Song L", "Schreuder FH", "Lindley RI", "Woodward M", "MacMahon S", "Salman RA", "Chow CK", "Chalmers J"], "date": "2022-12-01T00:00:00Z", "doi": "10.1177/17474930211068671", "meta_date_publication": "2022 Dec", "meta_volume": "17", "meta_issue": "10", "meta_pages": "1156-1162", "score": 50229.4, "text_hl": "OBJECTIVES: The Triple Therapy Prevention of Recurrent @DISEASE_Cerebral_Hemorrhage @DISEASE_MESH:D002543 @@@Intracerebral Disease@@@ Events Trial (TRIDENT) aims to determine the effects of a novel SPC \"Triple Pill,\" three generic antihypertensive drugs with demonstrated efficacy and complementary mechanisms of action at half standard dose (@CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@ 20 mg, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ 2.5 mg, and @CHEMICAL_Indapamide @CHEMICAL_MESH:D007190 @@@indapamide@@@ 1.25 mg), with placebo for the prevention of recurrent @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@, cardiovascular events, and @<m>DISEASE_Cognition_Disorders</m> @DISEASE_MESH:D003072 @@@cognitive impairment@@@ after @DISEASE_Cerebral_Hemorrhage @DISEASE_MESH:D002543 @@@ICH@@@. ", "citations": {"NLM": "Anderson CS, Rodgers A, de Silva HA, Martins SO, Klijn CJ, Senanayake B, Freed R, Billot L, Arima H, Thang NH, Zaidi WAW, Kherkheulidze T, Wahab K, Fisher U, Lee TH, Chen C, Pontes-Neto O, Robinson T, Wang J, Naismith S, Song L, Schreuder FH, Lindley RI, Woodward M, MacMahon S, Salman RA, Chow CK, Chalmers J. Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress. Int J Stroke. 2022 Dec;17(10):1156-1162. PMID: 34994269", "BibTeX": "@article{34994269, title={Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress.}, author={Anderson CS and Rodgers A and de Silva HA and Martins SO and Klijn CJ and Senanayake B and Freed R and Billot L and Arima H and Thang NH and Zaidi WAW and Kherkheulidze T and Wahab K and Fisher U and Lee TH and Chen C and Pontes-Neto O and Robinson T and Wang J and Naismith S and Song L and Schreuder FH and Lindley RI and Woodward M and MacMahon S and Salman RA and Chow CK and Chalmers J}, journal={Int J Stroke}, volume={17}, number={10}, pages={1156-1162}}"}}, {"_id": "17325591", "pmid": 17325591, "title": "Favourable effects of nilvadipine on cognitive function and regional cerebral blood flow on SPECT in hypertensive patients with mild cognitive impairment.", "journal": "Nucl Med Commun", "authors": ["Hanyu H", "Hirao K", "Shimizu S", "Iwamoto T", "Koizumi K", "Abe K"], "date": "2007-04-01T00:00:00Z", "doi": "10.1097/MNM.0b013e32804c58aa", "meta_date_publication": "2007 Apr", "meta_volume": "28", "meta_issue": "4", "meta_pages": "281-7", "score": 50057.098, "text_hl": "OBJECTIVE: We compared the effects of @CHEMICAL_nilvadipine @CHEMICAL_MESH:C035100 @@@nilvadipine@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on the cognitive function and regional cerebral blood flow (rCBF) in @SPECIES_9606 @@@patients@@@ with mild @<m>DISEASE_Cognition_Disorders</m> @DISEASE_MESH:D003072 @@@cognitive impairment@@@ (@DISEASE_Cognitive_Dysfunction @DISEASE_MESH:D060825 @@@MCI@@@) and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@. ", "citations": {"NLM": "Hanyu H, Hirao K, Shimizu S, Iwamoto T, Koizumi K, Abe K. Favourable effects of nilvadipine on cognitive function and regional cerebral blood flow on SPECT in hypertensive patients with mild cognitive impairment. Nucl Med Commun. 2007 Apr;28(4):281-7. PMID: 17325591", "BibTeX": "@article{17325591, title={Favourable effects of nilvadipine on cognitive function and regional cerebral blood flow on SPECT in hypertensive patients with mild cognitive impairment.}, author={Hanyu H and Hirao K and Shimizu S and Iwamoto T and Koizumi K and Abe K}, journal={Nucl Med Commun}, volume={28}, number={4}, pages={281-7}}"}}, {"_id": "30359218", "pmid": 30359218, "title": "[Cognitive Disorders and Dementia in Old Patients With Arterial Hypertension].", "journal": "Kardiologiia", "authors": ["Ostroumova OD", "Starodubova AV", "Ostroumova TM", "Cherniaeva MS"], "date": "2018-10-01T00:00:00Z", "meta_date_publication": "2018 Oct", "meta_volume": "", "meta_issue": "10", "meta_pages": "71-79", "score": 50052.19, "text_hl": "The evidence base of @CHEMICAL_1_4_dihydropyridine @CHEMICAL_MESH:C038806 @@@dihydropyridine@@@ @CHEMICAL_Calcium @CHEMICAL_MESH:D002118 @@@calcium@@@ antagonist @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @CHEMICAL_Thiazides @CHEMICAL_MESH:D049971 @@@thiazide@@@-like diuretic @CHEMICAL_Indapamide @CHEMICAL_MESH:D007190 @@@indapamide@@@-retard is discussed with respect to the prevention of @DISEASE_Dementia @DISEASE_MESH:D003704 @@@dementia@@@ and @<m>DISEASE_Cognition_Disorders</m> @DISEASE_MESH:D003072 @@@cognitive decline@@@ and their beneficial effect on cognitive function in @SPECIES_9606 @@@patients@@@ with @DISEASE_Pulmonary_Arterial_Hypertension @DISEASE_MESH:D000081029 @@@arterial hypertension@@@.", "citations": {"NLM": "Ostroumova OD, Starodubova AV, Ostroumova TM, Cherniaeva MS. [Cognitive Disorders and Dementia in Old Patients With Arterial Hypertension]. Kardiologiia. 2018 Oct;(10):71-79. PMID: 30359218", "BibTeX": "@article{30359218, title={[Cognitive Disorders and Dementia in Old Patients With Arterial Hypertension].}, author={Ostroumova OD and Starodubova AV and Ostroumova TM and Cherniaeva MS}, journal={Kardiologiia}, number={10}, pages={71-79}}"}}, {"_id": "22664571", "pmid": 22664571, "title": "Combination therapy of atorvastatin and amlodipine inhibits sympathetic nervous system activation and improves cognitive function in hypertensive rats.", "journal": "Circ J", "authors": ["Kishi T", "Sunagawa K"], "date": "2012-01-01T00:00:00Z", "doi": "10.1253/circj.cj-12-0276", "meta_date_publication": "2012", "meta_volume": "76", "meta_issue": "8", "meta_pages": "1934-41", "score": 50051.668, "text_hl": "The aim of the present study was to determine whether a combination of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ causes sympathoinhibition via reduction of oxidative stress in the RVLM and improves @<m>DISEASE_Cognition_Disorders</m> @DISEASE_MESH:D003072 @@@cognitive dysfunction@@@ of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Kishi T, Sunagawa K. Combination therapy of atorvastatin and amlodipine inhibits sympathetic nervous system activation and improves cognitive function in hypertensive rats. Circ J. 2012;76(8):1934-41. PMID: 22664571", "BibTeX": "@article{22664571, title={Combination therapy of atorvastatin and amlodipine inhibits sympathetic nervous system activation and improves cognitive function in hypertensive rats.}, author={Kishi T and Sunagawa K}, journal={Circ J}, volume={76}, number={8}, pages={1934-41}}"}}]}